Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Notch Signaling Pathway

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

Notch Signaling Pathway

Notch Signaling Pathway

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Tumor Progression

Tumor Progression

Bone Formation by Endochondral Ossification

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hybrid surgical approach for chronic pancreatitis: pyloric-ring-resection pancreaticoduodenectomy with lateral pancreatojejunostomy.

Journal of surgical case reports·2026

Same author

Empiric antifungals do not decrease the risk for organ space infection in patients with perforated peptic ulcer.

Trauma surgery & acute care open·2021

Same author

Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy.

Paediatric drugs·2015

Same author

New, tolerable γ-secretase inhibitor takes desmoid down a notch.

Clinical cancer research : an official journal of the American Association for Cancer Research·2014

Same author

Understanding the role of Notch in osteosarcoma.

Advances in experimental medicine and biology·2014

Same author

The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.

Pharmaceutical research·2013

Search research articles

Related Experiment Video

Updated: Apr 28, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Developmental pathways hijacked by osteosarcoma.

Jared R Mortus¹, Yi Zhang, Dennis P M Hughes

¹The College of Natural Sciences, The University of Texas at Austin, Austin, TX, USA.

Advances in Experimental Medicine and Biology

|June 14, 2014

Summary

This summary is machine-generated.

Osteosarcoma development is linked to disruptions in normal osteoblast development pathways like RUNX2, HIPPO/YAP, and Her-4. Understanding these pathways may reveal new therapeutic targets for osteosarcoma.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Related Experiment Videos

Last Updated: Apr 28, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Area of Science:

Cell biology
Developmental biology
Oncology

Background:

Osteosarcoma genesis involves disruptions in normal osteoblast development.
RUNX2 expression is critical for osteoblast maturation.
Multiple signaling pathways regulate osteoblast differentiation.

Purpose of the Study:

To explore the relationship between normal osteoblast development and osteosarcoma.
To identify key signaling pathways dysregulated in osteosarcoma.
To understand how pathway disruptions contribute to osteosarcoma phenotypes.

Main Methods:

Review of developmental biology and osteosarcoma literature.
Analysis of signaling pathways including BMP, Wnt/β-catenin, FGF, PKC, HIPPO/YAP, and Her-4.
Correlation of pathway disruptions with osteosarcoma characteristics.

Main Results:

Osteosarcoma cells may be arrested at the immature osteoblast stage.
Dysregulation of RUNX2, HIPPO/YAP, and Her-4 pathways is implicated in osteosarcoma.
Receptor tyrosine kinases like ERBB family members activate PKC in osteosarcoma.

Conclusions:

Understanding osteoblast development pathways offers insights into osteosarcoma mechanisms.
Pathway disruptions explain osteosarcoma phenotypes like invasiveness and ossification.
Targeting these developmental pathways may lead to novel osteosarcoma therapies.